Kathrin Brockmann is senior consultant and head of the outpatient clinic for Parkinson’s Disease (PD) at the department of neurodegenerative diseases at the Center of Neurology, University of Tübingen. As research group leader at the Hertie Institute for Clinical Brain Research in Tübingen, Dr. Brockmann’s main areas of research are large-scale longitudinal studies to better understand the different phases of neurodegeneration as well as symptom development and progression in PD. In this context, she focuses on stratification of patients according to genetic architecture and the underlying pathologic processes, reflected by profiles of their biomaterials. This approach allows her to directly translate research findings into the clinic and to introduce people with PD to pathway-specific therapies.